Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 4529 - 4536 of 11613 results
Join Us for a Webinar on MA Paid Family and Medical Leave
August 30, 2019| Blog| Viewpoint
The Future Of Int'l Mediation After The Singapore Convention
August 29, 2019| News
Investment Fund to Pay More Than $600,000 for Inadvertent Violation of HSR Act
August 29, 2019| Alert| Viewpoint
Telemedicine Platform Recalled Over Failure to Obtain Pre-Market Clearance or Approval from FDA
August 29, 2019| Blog| Viewpoint
Immigration Updates
August 28, 2019| Alert| Viewpoint
GAO Studies Use of PBMs in Medicare Part D
August 27, 2019| Blog| Viewpoint
All Complaints Once Served—Even Defective Complaints that are Dismissed—Trigger the IPR Time Bar
August 27, 2019| Blog| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.